Coronary Stenting with the Sirolimus-Eluting Stent in Clinical Practice: Final Results from the Prospective Multicenter German Cypher Stent Registry |
| |
Authors: | RALF ZAHN MD CHRISTIAN W HAMM MD STEFFEN SCHNEIDER PhD GERT RICHARDT MD MALTE KELM MD BENNY LEVENSON MD TASSILO BONZEL MD ULRICH TEBBE MD GEORG SABIN MD CHRISTOPH A NIENABER MD for the German Cypher Stent Registry |
| |
Institution: | From the Herzzentrum, Kardiologie, Ludwigshafen;, Kerckhoff Klinik, Kardiologie, Bad Nauheim;, Institut für Herzinfarktforschung, Ludwigshafen;;Segeberger Kliniken, Kardiologie, Bad Segeberg;;Universitätsklinikum, Kardiologie, Aachen;;Kardiologische Praxis, Berlin;;Klinikum Fulda, Kardiologie, Fulda;;Klinikum Lippe-Detmold, Kardiologie, Detmold;;Elisabeth Krankenhaus, Kardiologie, Essen;;and Universitätsklinikum, Kardiologie, Rostock |
| |
Abstract: | Aims: Drug-eluting coronary stents (DES) have gained widespread use for the treatment of coronary artery disease. However, because of safety concerns and frequent "off-label" use data from "real life," registries are necessary to monitor indications and outcome of DES in daily clinical practice. Methods and Results: We evaluated data from the German Cypher Stent Registry. A total of 10,894 patients treated with at least one sirolimus-eluting stent (SES) at 152 hospitals were included. Follow-up at a median of 6.4 months was available in 10,006 patients (92%). Median age was 64.8 years and 75.5% were male. Per lesion a mean of 1.09 ± 0.41 SES were implanted with a mean length of 21.1 ± 11.5mm. During follow-up, death rate was 1.8% and the rates of myocardial infarction or stroke were 2.1% and 0.5%. Any target vessel revascularization (TVR) was performed in 8.0% of patients. Independent predictors for death, myocardial infarction, or stroke were: cardiogenic shock, acute coronary syndromes, reduced left ventricular function, renal insufficiency, diabetes mellitus, advanced age, three-vessel disease, degree of stenosis, and prior myocardial infarction. Predictors for a TVR were: two- or three-vessel disease, target vessel = coronary bypass, advanced age, stent diameter, ostial lesions, indication in-stent restenosis, renal failure, and target vessel = left anterior descended artery. Conclusions: These results demonstrate that SES use in clinical practice is safe and effective. The main predictors of clinical events during follow-up are clinical parameters whereas as predictors of TVR mainly are angiographic parameters. (J Interven Cardiol 2010;23:18–25) |
| |
Keywords: | |
|
|